Geraghty James A
SEC-identified person · CIK 1239746 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Voyager Therapeutics, Inc. VYGR | Director | filed 2015 - 2026 |
| Fulcrum Therapeutics, Inc. FULC | Director | filed 2019 - 2025 |
| Pieris Pharmaceuticals, INC. PVLA | Director | filed 2017 - 2024 |
| Orchard Therapeutics plc ORTX | Director | filed 2020 - 2024 |
| Idera Pharmaceuticals, INC. IDRA | Director | filed 2013 - 2022 |
| Juniper Pharmaceuticals INC cbrx | Director | filed 2015 - 2018 |
| Genzyme Corp u4yfvwk$ | Senior Vice President | filed 2008 - 2011 |
| GTC Biotherapeutics INC GTCB | Director | filed 2006 - 2010 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.